1 / 40

Imaging AD Progression

Imaging AD Progression. Amyloid Imaging Agents. Potential Clinical Roles for Amyloid Imaging Presented at SNMMI 2014. Longitudinal Amyloid PET in Patients With MCI. Presence of Brain Amyloid and Accelerated Cognitive Decline. Aβ Burden in People With Subjective Memory Complaints.

gazelle-turner
Télécharger la présentation

Imaging AD Progression

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Imaging AD Progression

  2. Amyloid Imaging Agents

  3. Potential Clinical Roles for Amyloid Imaging Presented at SNMMI 2014

  4. Longitudinal Amyloid PET in Patients With MCI

  5. Presence of Brain Amyloid and Accelerated Cognitive Decline

  6. Aβ Burden in People With Subjective Memory Complaints

  7. More Complex Clinical Scenarios

  8. Late-life Depression and Amyloid Accumulation in MCI

  9. Post-stroke Dementia

  10. Conclusions

  11. Amyloid PET Imaging

  12. Amyloid PET Tracers

  13. A Negative Florbetaben PET Scan Reliably Excludes Amyloid Pathology as Confirmed by Histopathology

  14. Prevalence of Aβ PET Positivity Across Dementia Syndromes

  15. Prevalence of Aβ PET Positivity Across Dementia Syndromes (cont)

  16. Imaging MCI With A Second-Generation Tracer

  17. Diagnostic Value of Amyloid Imaging in Early-Onset Dementia

  18. Amyloid PET Has Greater Clinical Impact Than FDG PET in the Differential Diagnosis of AD and FTD

  19. Conclusions

  20. Vascular Risk Factors Impact Cognition Independent of PiB PET and MRI Measures of AD and Vascular Brain Injury

  21. Existing Thresholds for PiB Positivity Are Too High

  22. Physical Activity Modifies Alzheimer Biomarkers in Preclinical AD

  23. Imaging of Tau Pathology in Patients with Non-AD Tauopathies

  24. Abbreviations

  25. References

  26. References (cont)

  27. References (cont)

  28. References (cont)

  29. References (cont)

More Related